Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab

NCT03745586 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Arteritis

Interventions

DRUG: Tocilizumab
DRUG: Glucocorticoids

Sponsor

Insel Gruppe AG, University Hospital Bern